Arkolith/Insider Trading/ARTL/Form 4

Kelly Steven

DirectorARTELO BIOSCIENCES, INC. (ARTL) · full profile →Form 4 · filed Mar 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2024Disposed to issuer(D)10K——0
Feb 28, 2024Grant(A)1K——1K
Feb 28, 2024Disposed to issuer(D)667——0
Feb 28, 2024Disposed to issuer(D)667——0
Feb 28, 2024Disposed to issuer(D)1K——0
Feb 28, 2024Grant(A)1K——1K
Feb 28, 2024Grant(A)10K——10K
Feb 28, 2024Disposed to issuer(D)1K——0
Feb 28, 2024Disposed to issuer(D)667——0
Feb 28, 2024Grant(A)667——667
Feb 28, 2024Grant(A)667——667
Feb 28, 2024Grant(A)667——667

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640334-24-000333) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML